4//SEC Filing
Neylan John F. 4
Accession 0001601485-22-000013
CIK 0001601485other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:21 PM ET
Size
7.7 KB
Accession
0001601485-22-000013
Insider Transaction Report
Form 4
Neylan John F.
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2022-03-02+175,000→ 175,000 totalExercise: $1.99Exp: 2032-03-01→ Common Stock (175,000 underlying) - Award
Stock Option (Right to Buy)
2022-03-02+100,000→ 275,000 totalExercise: $1.99Exp: 2032-03-01→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- [F2]The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022.
Documents
Issuer
Angion Biomedica Corp.
CIK 0001601485
Entity typeother
Related Parties
1- filerCIK 0001640447
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:21 PM ET
- Size
- 7.7 KB